Annals ofAutoimmunity

Volume: 1 - Number: 6 - September 19, 2002

Outstanding

Molecular Pathogenesis of the Antiphospholipid Syndrome

Thrombogenic Effects of Antiphospholipid Antibodies Are Mediated by Intercellular Cell Adhesion Molecule-1, Vascular Cell Adhesion Molecule-1, and P-Selectin

Hypercoagulable State in Patients With Antiphospholipid Syndrome Is Related to High Induced Tissue Factor Expression on Monocytes and to Low Free Protein S

Bacterial induction of autoantibodies to ß2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome

Articles

Antiphospholipid Antibodies From Antiphospholipid Syndrome Patients Activate Endothelial Cells In Vitro and In Vivo

Molecular Pathogenesis of the Antiphospholipid Syndrome

Seasonal Distribution of Antiphospholipid Antibodies

2001: A Prospective, Seasonal Odyssey Into Antiphospholipid Protein Antibodies

Anticardiolipin Antibodies From Patients With the Antiphospholipid Antibody Syndrome Recognize Epitopes in Both ß2-Glycoprotein 1 and Oxidized Low-Density Lipoprotein

Thrombogenic Effects of Antiphospholipid Antibodies Are Mediated by Intercellular Cell Adhesion Molecule-1, Vascular Cell Adhesion Molecule-1, and P-Selectin

Factor V Leiden and Antiphospholipid Antibodies Are Significant Risk Factors for Ischemic Stroke in Children

Neurometabolite Markers of Cerebral Injury in the Antiphospholipid Antibody Syndrome of Systemic Lupus Erythematosus

Antiphospholipid-Protein Antibodies and Ischemic Stroke : Not Just Cardiolipin Anymore

Antiphospholipid Syndrome in the Elderly: Caution

Differential Effects of Anti ß2-Glycoprotein I Antibodies on Endothelial Cells and on the Manifestations of Experimental Antiphospholipid Syndrome

Hydroxychloroquine Reverses Thrombogenic Properties of Antiphospholipid Antibodies in Mice

Hypercoagulable State in Patients With Antiphospholipid Syndrome Is Related to High Induced Tissue Factor Expression on Monocytes and to Low Free Protein S

Thrombogenic Properties of Murine Anti-Cardiolipin Antibodies Induced by ß2 Glycoprotein 1 and Human Immunoglobulin G Antiphospholipid Antibodies

Heart Valve Involvement (Libman-Sacks Endocarditis) in the Antiphospholipid Syndrome

Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: a prospective cohort study

Restricted T-cell receptor -chain usage by T cells autoreactive to 2-glycoprotein I in patients with antiphospholipid syndrome

Autoreactive CD4+ T-cell clones to 2-glycoprotein I in patients with antiphospholipid syndrome: preferential recognition of the major phospholipid-binding site

The clonal analysis of anticardiolipin antibodies in a single patient with primary antiphospholipid syndrome reveals an extreme antibody heterogeneity

Bacterial induction of autoantibodies to ß2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome

Warfarin or Aspirin for Recurrent Ischemic Stroke

Medical Progress: The Antiphospholipid Syndrome

Oral Anticoagulant Therapy for the Prevention of Stroke

Advances in Immunology: Immunomodulation of Autoimmune and Inflammatory Diseases with Intravenous Immune Globulin

Cerebral Sinovenous Thrombosis in Children

Superficial Thrombophlebitis

Mutations in Coagulation Factors in Women with Unexplained Late Fetal Loss